Overview

Bioequivalence Study of Test and Reference Testosterone Topical Gel, 1.62% Metered Pump in Testosterone Deficient Adult Male Subjects Under Fasting Conditions

Status:
Completed
Trial end date:
2014-05-01
Target enrollment:
Participant gender:
Summary
Bioequivalence study comparing the rate and extent of testosterone absorption for a test formulation versus the reference product.
Phase:
Phase 3
Details
Lead Sponsor:
Amneal Pharmaceuticals, LLC
Collaborator:
Phase One Solutions, Inc.
Treatments:
Methyltestosterone
Testosterone
Testosterone 17 beta-cypionate
Testosterone enanthate
Testosterone undecanoate